Product NDC: | 25021-201 |
Proprietary Name: | Mesna |
Non Proprietary Name: | mesna |
Active Ingredient(s): | 100 mg/mL & nbsp; mesna |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-201 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090913 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101201 |
Package NDC: | 25021-201-68 |
Package Description: | 1 VIAL in 1 CARTON (25021-201-68) > 10 mL in 1 VIAL |
NDC Code | 25021-201-68 |
Proprietary Name | Mesna |
Package Description | 1 VIAL in 1 CARTON (25021-201-68) > 10 mL in 1 VIAL |
Product NDC | 25021-201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mesna |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101201 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | MESNA |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cytoprotective Agent [EPC] |